These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

241 related items for PubMed ID: 8383197

  • 1. Epithelial (E-) and placental (P-) cadherin cell adhesion molecule expression in breast carcinoma.
    Rasbridge SA, Gillett CE, Sampson SA, Walsh FS, Millis RR.
    J Pathol; 1993 Feb; 169(2):245-50. PubMed ID: 8383197
    [Abstract] [Full Text] [Related]

  • 2. Differential expression of E-cadherin in lobular and ductal neoplasms of the breast and its biologic and diagnostic implications.
    Acs G, Lawton TJ, Rebbeck TR, LiVolsi VA, Zhang PJ.
    Am J Clin Pathol; 2001 Jan; 115(1):85-98. PubMed ID: 11190811
    [Abstract] [Full Text] [Related]

  • 3. Expression of sialyl lewis X, sialyl Lewis A, E-cadherin and cathepsin-D in human breast cancer: immunohistochemical analysis in mammary carcinoma in situ, invasive carcinomas and their lymph node metastasis.
    Jeschke U, Mylonas I, Shabani N, Kunert-Keil C, Schindlbeck C, Gerber B, Friese K.
    Anticancer Res; 2005 Jan; 25(3A):1615-22. PubMed ID: 16033070
    [Abstract] [Full Text] [Related]

  • 4. Simultaneous loss of E-cadherin and catenins in invasive lobular breast cancer and lobular carcinoma in situ.
    De Leeuw WJ, Berx G, Vos CB, Peterse JL, Van de Vijver MJ, Litvinov S, Van Roy F, Cornelisse CJ, Cleton-Jansen AM.
    J Pathol; 1997 Dec; 183(4):404-11. PubMed ID: 9496256
    [Abstract] [Full Text] [Related]

  • 5. Anomalous expression of P-cadherin in breast carcinoma. Correlation with E-cadherin expression and pathological features.
    Palacios J, Benito N, Pizarro A, Suárez A, Espada J, Cano A, Gamallo C.
    Am J Pathol; 1995 Mar; 146(3):605-12. PubMed ID: 7534041
    [Abstract] [Full Text] [Related]

  • 6. Differential loss of E-cadherin expression in infiltrating ductal and lobular breast carcinomas.
    Moll R, Mitze M, Frixen UH, Birchmeier W.
    Am J Pathol; 1993 Dec; 143(6):1731-42. PubMed ID: 8256859
    [Abstract] [Full Text] [Related]

  • 7. Correlation of E-cadherin expression with differentiation grade and histological type in breast carcinoma.
    Gamallo C, Palacios J, Suarez A, Pizarro A, Navarro P, Quintanilla M, Cano A.
    Am J Pathol; 1993 Apr; 142(4):987-93. PubMed ID: 7682767
    [Abstract] [Full Text] [Related]

  • 8. Does the level of E-cadherin expression correlate with the primary breast carcinoma infiltration pattern and type of systemic metastases?
    Goldstein NS.
    Am J Clin Pathol; 2002 Sep; 118(3):425-34. PubMed ID: 12219785
    [Abstract] [Full Text] [Related]

  • 9. Role of E-cadherins in development of lymphatic tumor emboli.
    Gupta A, Deshpande CG, Badve S.
    Cancer; 2003 May 01; 97(9):2341-7. PubMed ID: 12712492
    [Abstract] [Full Text] [Related]

  • 10. E-cadherin expression in invasive non-lobular carcinoma of the breast and its prognostic significance.
    Rakha EA, Abd El Rehim D, Pinder SE, Lewis SA, Ellis IO.
    Histopathology; 2005 Jun 01; 46(6):685-93. PubMed ID: 15910600
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Immunolocalization of the fodrin, E-cadherin, and beta-catenin adhesion complex in infiltrating ductal carcinoma of the breast-comparison with an in vitro model.
    Sormunen RT, Leong AS, Vääräniemi JP, Fernando SS, Eskelinen SM.
    J Pathol; 1999 Mar 01; 187(4):416-23. PubMed ID: 10398100
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. E-cadherin expression in primary carcinomas of the breast and its distant metastases.
    Kowalski PJ, Rubin MA, Kleer CG.
    Breast Cancer Res; 2003 Mar 01; 5(6):R217-22. PubMed ID: 14580257
    [Abstract] [Full Text] [Related]

  • 17. D2-40 expression by breast myoepithelium: potential pitfalls in distinguishing intralymphatic carcinoma from in situ carcinoma.
    Rabban JT, Chen YY.
    Hum Pathol; 2008 Feb 01; 39(2):175-83. PubMed ID: 18206495
    [Abstract] [Full Text] [Related]

  • 18. Clinicopathologic implications of E-cadherin reactivity in patients with lobular carcinoma in situ of the breast.
    Goldstein NS, Kestin LL, Vicini FA.
    Cancer; 2001 Aug 15; 92(4):738-47. PubMed ID: 11550142
    [Abstract] [Full Text] [Related]

  • 19. Expression patterns of beta-catenin in in situ and invasive breast cancer.
    Karayiannakis AJ, Nakopoulou L, Gakiopoulou H, Keramopoulos A, Davaris PS, Pignatelli M.
    Eur J Surg Oncol; 2001 Feb 15; 27(1):31-6. PubMed ID: 11237489
    [Abstract] [Full Text] [Related]

  • 20. [Expression of E-cadherine as a differential diagnostic fest for lobular infiltrative breast cancers].
    Chipysheva TA, Ermilova VD, Vishnevskaia IaV, Vasil'ev IuM.
    Arkh Patol; 2005 Feb 15; 67(6):24-7. PubMed ID: 16405017
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.